|
Synonyms: (S)-FAH65
Compound class:
Synthetic organic
Comment: FAH65 is a beta-secretase 1 (BACE1) inhibitor [1] (with PubChem CID 138468551). Bioactivity resides in the (S)-enantiomer named FAH65E(-), as curated in this entry. The (R)-enantiomer is inactive. In vitro and in vivo profiling suggests that FAH65/FAH65E(-) might have therapeutic potential for the treament of Alzheimer's disease.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Campagna J, Jagodzinska B, Wi D, Zhu C, Lee J, Cohn W, Jun M, Elias C, Padder S, Descamps O et al.. (2025)
Discovery of an APP-selective BACE1 inhibitor for Alzheimer's disease. Neurotherapeutics, 22 (5): e00610. [PMID:40399225] |